$1.65
0.02[1.23%]
At close: Apr 18
$1.65
0[0.00%]
PreMarket: 7:38PM EDT
Lexicon Pharmaceuticals
(NASDAQ:LXRX)Lexicon Pharmaceuticals Stock (NASDAQ:LXRX), Earnings Estimates, EPS, and Revenue
Lexicon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 30
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$1.9M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.2M
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2024 | PM | LXRX | Q1 | -$0.17 | -$0.23 | — | — | $24.00K | $1.89M | — | — | Get Alert |
| 03/11/2024 | AM | LXRX | Q4 | -$0.16 | -$0.22 | -$0.20 | 9.09% | $28.00K | $1.24M | $702.00K | -43.39% | Get Alert |
| 11/08/2023 | AM | LXRX | Q3 | -$0.13 | -$0.21 | -$0.21 | 0.00% | $39.00K | $2.06M | $162.00K | -92.14% | Get Alert |
| 08/03/2023 | PM | LXRX | Q2 | -$0.16 | -$0.17 | -$0.22 | -29.41% | $35.00K | $70.00K | $317.00K | 352.86% | Get Alert |
| 05/02/2023 | PM | LXRX | Q1 | -$0.16 | -$0.18 | -$0.17 | 5.56% | $37.00K | $30.00K | $24.00K | -20.00% | Get Alert |
| 03/02/2023 | PM | LXRX | Q4 | -$0.17 | -$0.13 | -$0.16 | -23.08% | $14.00K | $50.00K | $28.00K | -44.00% | Get Alert |
| 11/09/2022 | PM | LXRX | Q3 | -$0.16 | -$0.14 | -$0.13 | 7.14% | $23.00K | $50.00K | $39.00K | -22.00% | Get Alert |
| 08/02/2022 | PM | LXRX | Q2 | -$0.13 | -$0.16 | -$0.16 | 0.00% | $234.00K | $50.00K | $35.00K | -30.00% | Get Alert |
| 05/05/2022 | AM | LXRX | Q1 | -$0.15 | -$0.16 | -$0.16 | 0.00% | $27.00K | $50.00K | $37.00K | -26.00% | Get Alert |
| 02/28/2022 | AM | LXRX | Q4 | -$0.04 | -$0.18 | -$0.17 | 5.56% | $199.00K | — | $14.00K | — | Get Alert |
| 11/03/2021 | PM | LXRX | Q3 | -$0.43 | -$0.18 | -$0.16 | 11.11% | $6.63M | — | $23.00K | — | Get Alert |
| 07/30/2021 | AM | LXRX | Q2 | -$0.65 | -$0.16 | -$0.13 | 18.75% | $9.16M | $10.00K | $234.00K | 2240.00% | Get Alert |
| 05/06/2021 | PM | LXRX | Q1 | -$0.63 | -$0.16 | -$0.15 | 6.25% | $8.00M | $1.68M | $27.00K | -98.39% | Get Alert |
| 03/10/2021 | PM | LXRX | Q4 | -$0.48 | -$0.28 | -$0.04 | 85.71% | $8.73M | $110.00K | $199.00K | 80.91% | Get Alert |
| 10/29/2020 | AM | LXRX | Q3 | -$0.10 | $0.26 | -$0.43 | -265.38% | $294.45M | $16.87M | $6.63M | -60.68% | Get Alert |
| 07/30/2020 | AM | LXRX | Q2 | -$0.22 | -$0.61 | -$0.65 | -6.56% | $9.68M | $8.83M | $9.16M | 3.77% | Get Alert |
| 04/27/2020 | AM | LXRX | Q1 | -$0.21 | -$0.69 | -$0.63 | 8.70% | $9.22M | $7.79M | $8.00M | 2.68% | Get Alert |
| 03/12/2020 | AM | LXRX | Q4 | -$0.16 | -$0.77 | -$0.48 | 37.66% | $17.07M | $10.26M | $8.73M | -14.94% | Get Alert |
| 11/07/2019 | AM | LXRX | Q3 | -$0.26 | $0.73 | -$0.10 | -113.70% | $6.86M | $64.25M | $294.45M | 358.28% | Get Alert |
FAQ
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on March 11, 2024 for Q4.
What were the latest earnings per share (EPS) for Lexicon Pharmaceuticals (NASDAQ:LXRX)?
The Actual EPS was $-0.20, which beat the estimate of $-0.22.
What were Lexicon Pharmaceuticals’s (NASDAQ:LXRX) revenues?
The Actual Revenue was $702K, which missed the estimate of $1.2M.
Browse earnings estimates, EPS, and revenue on all stocks.